AHA GUIDELINES Bundle (free trial)

Chronic Coronary Disease 2023

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1504138

Contents of this Issue

Navigation

Page 24 of 65

25 Table 10. Very High-Risk* of Future ASCVD Events Definition of Very High-Risk* • History of multiple major ASCVD events OR • One major ASCVD event AND ≥2 high-risk conditions Major ASCVD Events • Recent ACS (within the past 12 mo) • History of MI (other than recent ACS events listed above) • History of ischemic stroke • Symptomatic peripheral artery disease (history of claudication with ABI <0.85, or previous revascularization or amputation) High-Risk Conditions • Age ≥65 y • Familial hypercholesterolemia † • History of previous coronary artery bypass graft surgery or percutaneous coronary intervention outside of the major ASCVD event(s) • Diabetes • Hypertension • Chronic kidney disease (eGFR, 15–59 mL/min/1.73m 2 ) • Current tobacco smoking • Persistently elevated LDL-C ≥100 mg/dL despite maximally tolerated statin therapy and ezetimibe • History of congestive heart failure * Very high-risk includes a history of multiple major ASCVD events or 1 major ASCVD event and multiple high-risk conditions. † Management of patients with familial hypercholesterolemia oen requires combination lipid lowering therapy and referral to a lipid specialist, and possibly lipoprotein apheresis. Gidding SS, et al. Circulation. 2015;132:2167-2192 and Goldberg AC J Clin Lipidol. 2011;5:S1-8. Modified with permission from Grundy SM, et al. op. cit. Copyright 2019 American Heart Association, Inc., and American College of Cardiolog y Foundation.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Chronic Coronary Disease 2023